Literature DB >> 2333747

Serum haemolytic classical and alternative pathways of complement in infancy: age-related changes.

V P Ferriani1, J E Barbosa, I F de Carvalho.   

Abstract

The haemolytic activity of complement was evaluated in the serum of healthy children from birth to 2 years of age using the kinetic method for the determination of the time needed to lyse 50% of target red cells (t 1/2). No sex-linked differences were observed in any of the age groups studied and the lowest lytic activity levels for both complement pathways were detected in neonates. The two pathways, however, showed different maturation patterns, i.e., lytic activity levels similar to those of adults were reached between the 1st and 3rd month of life (classical pathway) and around the 13th month (alternative pathway). In the age group of 7 to 24 months, the lytic activity of the classical pathway was higher than in adults. The present data permitted us to establish normal ranges of t 1/2 values for the classical and alternative pathways in serum of healthy neonates and children aged 1 to 24 months.

Entities:  

Mesh:

Year:  1990        PMID: 2333747     DOI: 10.1111/j.1651-2227.1990.tb11464.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  9 in total

1.  Intravenous immunoglobulin (IVIG) attenuates antibody binding in acute haemorrhagic immunopneumonitis in a rat model of complement-dependent lung injury.

Authors:  M Dantas; R S Costa; J E Barbosa; M S Graeff; W Sarti; I F De Carvalho
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

2.  Physiological activity of Aloe vera in pacu (Piaractus mesopotamicus) inoculated with Aeromonas hydrophila.

Authors:  Rudney Weiber Silva de Assis; Elisabeth Criscuolo Urbinati
Journal:  Fish Physiol Biochem       Date:  2020-03-28       Impact factor: 2.794

3.  Postoperative Outcomes in Infants Undergoing ABO-incompatible Heart Transplantation in the United States.

Authors:  Dhaval Chauhan; Vittorio Orlandi; Taufiek Konrad Rajab; Kareem Bedeir; Alexander Volfovsky; Suyog Mokashi
Journal:  Ann Thorac Surg       Date:  2021-09-25       Impact factor: 4.330

Review 4.  Recipient outcomes after ABO-incompatible liver transplantation: a systematic review and meta-analysis.

Authors:  Jian Wu; Sunyi Ye; Xiaofeng Xu; Haiyang Xie; Lin Zhou; Shusen Zheng
Journal:  PLoS One       Date:  2011-01-25       Impact factor: 3.240

Review 5.  Outcomes after liver transplantation in accordance with ABO compatibility: A systematic review and meta-analysis.

Authors:  Eung Chang Lee; Seong Hoon Kim; Sang-Jae Park
Journal:  World J Gastroenterol       Date:  2017-09-21       Impact factor: 5.742

6.  Long-term Outcomes of ABO-incompatible Pediatric Living Donor Liver Transplantation.

Authors:  Masaki Honda; Yasuhiko Sugawara; Masashi Kadohisa; Keita Shimata; Masataka Sakisaka; Daiki Yoshii; Keiichi Uto; Shintaro Hayashida; Yuki Ohya; Hidekazu Yamamoto; Hirotoshi Yamamoto; Yukihiro Inomata; Taizo Hibi
Journal:  Transplantation       Date:  2018-10       Impact factor: 4.939

Review 7.  Platelets in pediatric and neonatal sepsis: novel mediators of the inflammatory cascade.

Authors:  Daniel O'Reilly; Claire A Murphy; Richard Drew; Afif El-Khuffash; Patricia B Maguire; Fionnuala Ni Ainle; Naomi Mc Callion
Journal:  Pediatr Res       Date:  2021-10-28       Impact factor: 3.756

8.  Case Report: Successful ABO-Incompatible Deceased Donor Kidney Transplantation in an Infant Without Pre-transplant Immunological Treatment.

Authors:  Daqiang Zhao; Lan Zhu; Shengyuan Zhang; Zhiliang Guo; Lu Wang; Tianhui Pan; Rula Sa; Zhishui Chen; Jipin Jiang; Gang Chen
Journal:  Front Med (Lausanne)       Date:  2022-03-02

9.  The Innate Immune Response of Atlantic Salmon (Salmo salar) Is Not Negatively Affected by High Temperature and Moderate Hypoxia.

Authors:  Fábio S Zanuzzo; Anne Beemelmanns; Jennifer R Hall; Matthew L Rise; Anthony K Gamperl
Journal:  Front Immunol       Date:  2020-05-27       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.